Title: Heme Oxygenase-1 in Lung Disease
Volume: 11
Issue: 12
Author(s): Chintan M. Raval and Patty J. Lee
Affiliation:
Keywords:
Heme oxygenase, carbon monoxide, lung disease, oxidants, anti-oxidants, heme oxygenase-1 (HO-1), carbon monoxide (CO), anti-oxidant, anti-inflammatory, anti-apoptotic, ischemia-reperfusion (IR), chronic obstructive pulmonary disease (COPD), pulmonary arterial hypertension (PAH), lung cancer, asthma, endogenous defense, carcinogenic, infectious stresses, carotenoids, glutathione, a-tocopherol, superoxide dismutase, pleiotropic molecule, homeostasis, hepatosplenomegaly, lymphadenopathy, hepatic periportal inflammation, glomerulonephritis, adult respiratory distress syndrome (ARDS), thromboembolectomy, copper-zinc oxide dismutase, glutathione peroxidase, alveolar macrophages, complementary DNA (cDNA), alveolar-capillary barrier, edema, anoxia-reoxygenation injury, small-interfering RNA (siRNA), myeloproxidase, malondialdehyde, neutrophil count, cigarette smoke (CS), emphysema, hypertrophy, synaptic neurotransmission, angioplasty, stress response elements (StRE), Maf Recognition Elements (MARE), Carbon monoxide releasing molecules (CORMs), kernicterus, BTB and CNC homology-1, B-cell CLL/lymphoma 2, Basic leucine zipper, Kelch-like ECH-associated protein 1, Maf associated recognition elements
Abstract: The lungs are a major target for various inflammatory, oxidative, carcinogenic or infectious stressors, which result in a range of lung diseases. Induction of heme oxygenase-1 (HO-1) during acute and chronic lung processes is a crucial defense mechanism. HO-1 catalyzes the degradation of free cellular heme to iron, carbon monoxide (CO) and biliverdin which is eventually converted to bilirubin by biliverdin reductase. In addition to the degradation of free heme, a pro-oxidant, HO-1 exerts anti-oxidant, anti-inflammatory and anti-apoptotic properties via its reaction products. This review summarizes the regulation and protective roles of HO-1 and its reaction products in several in vitro and in vivo lung disease models, including acute lung injury, ischemia-reperfusion (IR)-induced lung injury, cigarette smoke and chronic obstructive pulmonary disease (COPD), pulmonary arterial hypertension (PAH), lung cancer and asthma. The therapeutic applications of HO-1 in the lung as well as potential complications of excessive HO-1 induction are also covered. In summary, the HO-1 system is a powerful endogenous defense strategy with immense therapeutic potential against a range of lung diseases if optimal levels and tissue targeting can be achieved.
